These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22494234)

  • 1. Treatment of opioid dependence and cancer pain with sublingual buprenorphine: a case report.
    Park EM; Suzuki J
    Am J Addict; 2012; 21(3):283-4. PubMed ID: 22494234
    [No Abstract]   [Full Text] [Related]  

  • 2. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
    Daitch J; Frey ME; Silver D; Mitnick C; Daitch D; Pergolizzi J
    Pain Physician; 2012 Jul; 15(3 Suppl):ES59-66. PubMed ID: 22786462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion from high-dose full-opioid agonists to sublingual buprenorphine reduces pain scores and improves quality of life for chronic pain patients.
    Daitch D; Daitch J; Novinson D; Frey M; Mitnick C; Pergolizzi J
    Pain Med; 2014 Dec; 15(12):2087-94. PubMed ID: 25220043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of opioid maintenance treatments when analgesic treatments are required].
    Laprevote V; Geoffroy PA; Rolland B; Leheup BF; Di Patrizio P; Cottencin O; Schwan R
    Presse Med; 2013; 42(7-8):1085-90. PubMed ID: 23518339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users.
    Nielsen S; Hillhouse M; Mooney L; Ang A; Ling W
    J Subst Abuse Treat; 2015 Jan; 48(1):70-6. PubMed ID: 25065489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine for chronic pain.
    Calderon R; Copenhaver D
    J Pain Palliat Care Pharmacother; 2013 Dec; 27(4):402-5. PubMed ID: 24245573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.
    Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP
    J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of heroin detoxification with buprenorphine in a psychiatric hospital in Japan.
    Nagano T; Kimoto S; Aso K; Komori T; Yamaguchi Y; Okamura K; Yamamoto N; Kishimoto T
    Neuropsychopharmacol Rep; 2020 Dec; 40(4):376-382. PubMed ID: 33107693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical case conference: unobserved "home" induction onto buprenorphine.
    Lee JD; McNeely J; Grossman E; Vocci F; Fiellin DA
    J Addict Med; 2014; 8(5):309-14. PubMed ID: 25254668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine.
    Moody DE
    Expert Opin Drug Metab Toxicol; 2013 Jun; 9(6):675-97. PubMed ID: 23537174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged-release opioid agonist therapy: qualitative study exploring patients' views of 1-week, 1-month, and 6-month buprenorphine formulations.
    Neale J; Tompkins CNE; Strang J
    Harm Reduct J; 2019 Apr; 16(1):25. PubMed ID: 30943990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
    Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative Buprenorphine.
    Wolfe RC
    J Perianesth Nurs; 2019 Aug; 34(4):867-870. PubMed ID: 31204269
    [No Abstract]   [Full Text] [Related]  

  • 14. Another Senseless Death - The Case for Supervised Injection Facilities.
    Wakeman SE
    N Engl J Med; 2017 Mar; 376(11):1011-1013. PubMed ID: 28296603
    [No Abstract]   [Full Text] [Related]  

  • 15. Transdermal buprenorphine (Butrans) for chronic pain.
    Med Lett Drugs Ther; 2011 Apr; 53(1362):31-2. PubMed ID: 21502936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Buprenorphine as a new alternative for detoxification of heroin addicts. It causes only mild withdrawal problems, abating quickly].
    Blennow G; Fergusson A; Medvedeo A
    Lakartidningen; 2000 Apr; 97(15):1830-3. PubMed ID: 10815411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experience of using injectable formulation of buprenorphine for the detoxification treatment of heroin dependence patients].
    Aso K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2009 Jun; 44(3):156-66. PubMed ID: 19618840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of cancer-related pain with transdermal buprenorphine: a report of three cases.
    Schriek P
    Support Care Cancer; 2004 Dec; 12(12):882-4. PubMed ID: 15480815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nalmefene Mistakenly Prescribed to Reduce Alcohol Consumption in Patients Under Buprenorphine Substitution Therapy Resulting in Acute Opioid Withdrawal: Management in an Emergency Setting.
    Pélissier F; Rougé Bugat ME; Nubukpo P; Franchitto N
    J Clin Psychopharmacol; 2016 Feb; 36(1):100-3. PubMed ID: 26658085
    [No Abstract]   [Full Text] [Related]  

  • 20. Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function.
    Sacerdote P; Franchi S; Gerra G; Leccese V; Panerai AE; Somaini L
    Brain Behav Immun; 2008 May; 22(4):606-13. PubMed ID: 18294814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.